Wicht F, Fisch H U, Nelles J, Raisin J, Allemann P, Preisig R
Department of Clinical Pharmacology, University of Berne, Switzerland.
Alcohol Clin Exp Res. 1995 Apr;19(2):356-61. doi: 10.1111/j.1530-0277.1995.tb01515.x.
Despite standardization, marked interindividual variation in the severity of the disulfiram-alcohol reaction (DAR) has been observed. We studied the DAR in 51 consecutive alcoholics with (n = 16) and without (n = 35) significant alcoholic liver disease. Clinical signs of the DAR were much weaker in the patients with compared with those patients without liver disease. Because acetaldehyde is thought to be the main cause of the DAR, we studied ethanol and acetaldehyde kinetics in 13 patients (6 females, 7 males) with alcoholic liver disease (documented by biopsy, clinical and/or radiological findings, and by quantitative liver function) [galactose elimination capacity (GEC) 4.2 +/- SD 1.0 mg/min/kg; aminopyrine breath test (ABT) 0.14 +/- 0.10% dose x kg/mmol CO2] and 13 age- and sex-matched controls (alcoholics without significant liver disease, GEC 7.1 +/- 0.7; ABT 0.81 +/- 0.35). Clinical signs of acetaldehyde toxicity during the DAR (flush, nausea, tachycardia, and blood pressure drop) were absent in alcoholic liver disease, but clearly evident in controls. Blood ethanol kinetics were similar in both groups, Cmax and area under the concentration-time curve (AUC) being 6.27 +/- 1.82 and 368.9 +/- 72.9 mmol x min/liter in alcoholic liver disease, and 6.62 +/- 1.71 and 377.6 +/- 124.5 in controls, respectively. In contrast, there was a strong (p < 0.001) difference in Cmax and AUC of acetaldehyde, respective values being 33.46 +/- 21.52 and 1463.8 +/- 762.5 mumol x min/liter in alcoholic liver disease, and 110.87 +/- 56.00 and 4162.0 +/- 2424.6 in controls.(ABSTRACT TRUNCATED AT 250 WORDS)
尽管进行了标准化,但已观察到双硫仑-酒精反应(DAR)的严重程度存在显著的个体差异。我们对51例连续的酗酒者进行了研究,其中有严重酒精性肝病的16例(n = 16),无严重酒精性肝病的35例(n = 35)。与无肝病的患者相比,有肝病的患者DAR的临床症状要轻得多。由于乙醛被认为是DAR的主要原因,我们研究了13例酒精性肝病患者(6名女性,7名男性,经活检、临床和/或放射学检查以及定量肝功能证实[半乳糖清除能力(GEC)4.2±标准差1.0 mg/min/kg;氨基比林呼气试验(ABT)0.14±0.10%剂量×kg/mmol CO2])和13名年龄及性别匹配的对照者(无严重肝病的酗酒者,GEC 7.1±0.7;ABT 0.81±0.35)的乙醇和乙醛动力学。酒精性肝病患者在DAR期间无乙醛中毒的临床症状(脸红、恶心、心动过速和血压下降),但在对照者中明显可见。两组的血液乙醇动力学相似,酒精性肝病组的Cmax和浓度-时间曲线下面积(AUC)分别为6.27±1.82和368.9±72.9 mmol·min/升,对照组分别为6.62±1.71和377.6±124.5。相反,乙醛的Cmax和AUC存在显著差异(p < 0.001),酒精性肝病组的相应值分别为33.46±21.52和1463.8±762.5 μmol·min/升,对照组分别为110.87±56.00和4162.0±2424.6。(摘要截短于250字)